{"meta":{"id":"https:\/\/api.iclient.ifeng.com\/ipadtestdoc?aid=ucms_7ysAfa7tO6B","type":"doc","o":"1","documentId":"ucms_7ysAfa7tO6B"},"body":{"newStatus":"1","documentId":"ucms_7ysAfa7tO6B","staticId":"ucms_7ysAfa7tO6B","title":"太极集团新药——芪灯明目胶囊进入研发新阶段","shareTitle":"太极集团新药——芪灯明目胶囊进入研发新阶段","thumbnail_doc":"","thumbnail":"","source":"证券时报","author":"","editorcode":"weMedia","editTime":"2020-08-12 11:33:00","updateTime":"2020\/08\/12 11:33:00","wapurl":"http:\/\/\/\/finance.ifeng.com\/c\/7ysAfa7tO6B","introduction":"","wwwurl":"http:\/\/\/\/finance.ifeng.com\/c\/7ysAfa7tO6B","commentsUrl":"ucms_7ysAfa7tO6B","commentCount":0,"text":"
证券时报e公司讯,从太极集团获悉,太极集团新药——芪灯明目胶囊已进入研发新阶段,在广州、重庆、温州、南京、郑州、北京、天津、哈尔滨等城市设有研究中心。芪灯明目胶囊是国内首个通过国家药审中心按照有条件批准程序上市注册,填补通过口服治疗糖尿病眼病黄斑水肿空白的新药,目前正进行糖尿病黄斑水肿受试者招募。<\/p>","img":[],"summary":"证券时报e公司讯,从太极集团获悉,太极集团新药——芪灯明目胶囊已进入研发新阶段,在广州、重庆、温州、南京、郑州、北京、天津、哈尔滨等城市设有研究中心。芪灯明目胶","sharesummary":"证券时报e公司讯,从太极集团获悉,太极集团新药——芪灯明目胶囊已进入研发新阶段,在广州、重庆、温州、南京、郑州、北京、天津、哈尔滨等城市设有研究中心。芪灯明目胶","commentType":"0","wemediaEAccountId":"706","showclient":"0","shareurl":"https:\/\/ishare.ifeng.com\/c\/s\/v002AGKZgNHgtig3IgUkRvHmkaZYgtDvTGvrcdUNcya2ufc__","praise":"0","like_num":"0"}}